Mindable Health
Mindable Health GmbH is a Berlin-based digital therapeutics company that develops CE-marked prescription mobile apps for treating panic disorder, agoraphobia, and social phobia, distributed via the German statutory health insurance reimbursement system to patients referred by licensed clinicians.
- Company typePrivate
- Founded2018
- HeadquartersBerlin, Germany
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Mindable Health does
Mindable Health GmbH is a Berlin-based digital health company founded in 2018 that develops CE-marked prescription mobile applications for the treatment of anxiety disorders. The company's product portfolio consists of two core apps: Mindable: Panic & Agoraphobia (PZN 17454202, ICD-10 F40.0 and F41.0) and Mindable: Social Phobia (PZN 19166938, ICD-10 F40.1). Both applications deliver structured cognitive behavioral therapy-based interventions including guided exercises, journaling functionality, real-time exposure level tracking, and for the social phobia app, a structured 12-week attention training program. The applications are classified as medical devices and were developed in cooperation with licensed psychotherapists.
The underlying technology is a regulated digital health platform certified to ISO 13485 (Quality Management) and ISO 27001 (Information Security) by TÜV, with servers hosted in Germany to meet stringent data protection requirements. Mindable operates a B2B2C distribution model: patients complete a diagnostic questionnaire and receive a prescription from a healthcare provider, after which the apps are reimbursed by all statutory health insurance providers in Germany and provided free of charge to patients. The company is co-founded by Linda Weber (CEO) and Eddie Rietz (CTO), and operates with a headcount of 11-50 employees. Clinical outcomes reported include 91% user recommendation rates for the Panic & Agoraphobia app and a 1-in-8 symptom-free rate after 8 weeks of use.
Revenue mechanics are tied entirely to the German DiGA-style reimbursement pathway, with no disclosed private payer, employer-sponsored, or out-of-pocket revenue streams. Marketing relies on content marketing (blog), self-diagnostic online tools, App Store presence, and dedicated clinician engagement resources. The company was an early participant in the Startupbootcamp Digital Health Berlin accelerator in 2018 and currently operates exclusively in Germany with no disclosed international expansion.
Mindable Health firmographics
Firmographics- Name
- Mindable Health
- Legal name
- Mindable Health GmbH
- Website
- https://mindable.health
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Mindable Health GmbH is a Berlin-based digital therapeutics company that develops CE-marked prescription mobile apps for treating panic disorder, agoraphobia, and social phobia, distributed via the German statutory health insurance reimbursement system to patients referred by licensed clinicians.
- Ownership category
- akta.pro rank
Mindable Health industry classification
Industry- Product category
- Digital Therapeutics
- NAICS
- Health Care and Social Assistance (62)
- SIC
- Services-Misc Health & Allied Services, Nec (8090), Services-Health Services (8000)
- akta.pro primary industry
- Behavioral Health & Neurocognitive Therapeutics (Digital) (HLACANAI)
- akta.pro secondary industry
- General Mental Health Therapy Platforms (Talk Therapy) (HLALAEAA)
Keywords
Where Mindable Health is headquartered
LocationHeadquarters
- HQ city
- Berlin
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
Mindable Health business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Statutory Health Insurance Reimbursement: Mindable apps are provided free of charge to patients via reimbursement from statutory health insurance providers in Germany. Healthcare providers prescribe the apps (PZN codes listed), and costs are covered through the German healthcare system.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Patient Access (Prescription-based) |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Mindable Health product offering
Product offeringCore offering
Mindable Health develops and sells CE-marked prescription mobile medical device applications that deliver structured cognitive behavioral therapy for anxiety disorders. Its two flagship apps—Mindable: Panic & Agoraphobia (PZN 17454202, ICD-10 F40.0/F41.0) and Mindable: Social Phobia (PZN 19166938, ICD-10 F40.1)—are prescribed by healthcare providers and reimbursed by all statutory health insurance providers in Germany.
Product overview
Mindable Health offers two distinct mobile medical device applications designed to treat anxiety-related disorders. Mindable: Panic & Agoraphobia addresses panic disorder and agoraphobia (F40.0, F41.0), while Mindable: Social Phobia targets social anxiety disorder (F40.1). Both apps provide cognitive behavioral therapy-based interventions including guided exercises, journaling, exposure tracking, and educational content. The apps are prescribed by healthcare providers and are reimbursed by all statutory health insurance providers in Germany.
Differentiator
Problem solved
Functional benefit
Brands
- Mindable: Panic & Agoraphobia: App for treating panic disorder and agoraphobia with PZN 17454202, F40.0/F41.0 classification.
- Mindable: Social Phobia
Products and services
- Mindable: Panic & Agoraphobia
Quantifiable outcome
- 91% of users would recommend the Mindable: Panic & Agoraphobia program
- +3 more outcomes
Companies that use Mindable Health
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles4 records
Mindable Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Mindable Health partnerships and signals
Strategic signalScale indicators4 records
Recent moves5 records
Expansion highlights4 records
Mindable Health competitors and assessment
Company assessmentDirect peers
- GAIA AG: GAIA is a leading German digital therapeutics company specializing in evidence-based DTx for mental health conditions including depression, anxiety, and insomnia. Like Mindable, GAIA's products are CE-marked and reimbursed through the German DiGA pathway, making it the closest direct competitor in the prescription DTx model.
- HelloBetter: HelloBetter (formerly GET.ON) is a German digital therapeutics company offering CE-marked, DiGA-reimbursed online courses for depression, stress, and chronic conditions. It operates the same prescription-based B2B2C model as Mindable through German statutory health insurance reimbursement.
- Selfapy: Selfapy is a Berlin-based digital therapeutics company offering DiGA-listed online therapy programs for depression, burnout, and anxiety. It directly competes with Mindable in the same prescription digital therapeutics channel targeting German statutory health insurers.
- Deprexis (now part of GAIA): Deprexis is an evidence-based digital therapeutic for depression that was among the first DiGA-approved apps in Germany. It shares Mindable's prescription-based CBT delivery model and reimbursement pathway through German statutory health insurers.
- Moodpath: Moodpath is a German-developed mental health app offering screening and psychoeducational modules for depression and anxiety. While its reimbursement status differs, it competes for the same anxious patient population and clinician prescribing relationships in Germany.
- Akili Interactive: Akili Interactive is a prescription digital therapeutics company that develops FDA-cleared cognitive treatment apps. It shares Mindable's regulatory pathway (FDA/CE cleared prescription DTx), though its indications (ADHD) differ from Mindable's anxiety focus.
- Sympatient: Sympatient is a German digital health company offering VR-based exposure therapy for anxiety disorders. It targets the same anxiety patient population and clinician prescribers in Germany, using a complementary VR modality to Mindable's mobile CBT approach.
Broad incumbents
- Headspace Health: Headspace Health (combining Headspace and Ginger) is a global mental health and wellness platform offering meditation, coaching, and therapy. It overlaps with Mindable's anxiety use cases at the consumer end and increasingly pursues B2B payer partnerships that mirror the German DiGA reimbursement model.
- Calm: Calm is a global consumer mental wellness brand offering meditation and sleep apps. It addresses the same anxious end-user population as Mindable through direct-to-consumer and employer channels, though it lacks Mindable's prescription medical-device positioning.
Emerging players
- Woebot Health: Woebot Health develops AI-driven conversational mental health tools for anxiety and depression management. It overlaps with Mindable's anxiety therapeutic area through a different delivery modality (chatbot vs. structured CBT program) and serves similar enterprise/payer customers.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Mindable Health social profiles
Digital presenceMindable Health compliance and trust
Trust signalCompliance2 records
Mindable Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Mindable Health leadership team
Management profileNumber of profiles
Profiles2 records
Mindable Health funding detail
Funding detailFunding overview
Funding rounds1 record
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Mindable Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Mindable Health
What does Mindable Health do?
Mindable Health develops and sells CE-marked prescription mobile medical device applications that deliver structured cognitive behavioral therapy for anxiety disorders. Its two flagship apps—Mindable: Panic & Agoraphobia (PZN 17454202, ICD-10 F40.0/F41.0) and Mindable: Social Phobia (PZN 19166938, ICD-10 F40.1)—are prescribed by healthcare providers and reimbursed by all statutory health insurance providers in Germany.
Is Mindable Health a public or private company?
Mindable Health is a private company. It is classified as venture growth investor backed and is currently operating.
When was Mindable Health founded?
Mindable Health was founded in 2018. It employs 11 to 50 people.
Where is Mindable Health based?
Mindable Health is headquartered in Berlin, Germany, in the Europe region.
How does Mindable Health make money?
One revenue line is on record: statutory Health Insurance Reimbursement.
Who are Mindable Health's main competitors?
Direct peers on record are GAIA AG, HelloBetter, Selfapy, Deprexis (now part of GAIA), Moodpath, Akili Interactive and Sympatient. Broad incumbents are Headspace Health and Calm. Woebot Health is listed as an emerging player.
Does Mindable Health have an API?
No public API is recorded for Mindable Health.
What industry is Mindable Health in?
Mindable Health's product category is Digital Therapeutics. Its primary akta.pro industry code is HLACANAI, Behavioral Health & Neurocognitive Therapeutics (Digital), with a secondary code of HLALAEAA, General Mental Health Therapy Platforms (Talk Therapy). Its NAICS code is 62 and its SIC code is 8090.